Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124692723 | 12469272 | 3 | F | 20160707 | 20160615 | 20160715 | EXP | US-ASTRAZENECA-2016SE64867 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160716 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124692723 | 12469272 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | 21366 | TABLET | |||||||||
| 124692723 | 12469272 | 2 | C | INSULIN | INSULIN NOS | 1 | 2-6 SHOTS PER DAY | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124692723 | 12469272 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124692723 | 12469272 | Ill-defined disorder | |
| 124692723 | 12469272 | Muscle atrophy | |
| 124692723 | 12469272 | Nausea | |
| 124692723 | 12469272 | Renal failure | |
| 124692723 | 12469272 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |